{"disease":{"id":"stage-ii-pancreatic-neuroendocrine-tumor-ajcc-v8","name":"stage ii pancreatic neuroendocrine tumor ajcc v8"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05040360","title":"Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":141,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":false},{"nct_id":"NCT05687123","title":"Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}